Bruker Gross Profit 2012-2026 | BRKR
Bruker annual/quarterly gross profit history and growth rate from 2012 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Bruker gross profit for the quarter ending March 31, 2026 was $0.380B, a 2.91% decline year-over-year.
- Bruker gross profit for the twelve months ending March 31, 2026 was $1.566B, a 7.2% decline year-over-year.
- Bruker annual gross profit for 2025 was $1.578B, a 4.35% decline from 2024.
- Bruker annual gross profit for 2024 was $1.65B, a 9% increase from 2023.
- Bruker annual gross profit for 2023 was $1.513B, a 15.9% increase from 2022.
|
Bruker Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $1,578 |
| 2024 | $1,650 |
| 2023 | $1,513 |
| 2022 | $1,306 |
| 2021 | $1,210 |
| 2020 | $940 |
| 2019 | $995 |
| 2018 | $900 |
| 2017 | $816 |
| 2016 | $745 |
| 2015 | $709 |
| 2014 | $763 |
| 2013 | $805 |
| 2012 | $829 |
| 2011 | $753 |
|
Bruker Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-03-31 | $380 |
| 2025-12-31 | $449 |
| 2025-09-30 | $379 |
| 2025-06-30 | $358 |
| 2025-03-31 | $391 |
| 2024-12-31 | $493 |
| 2024-09-30 | $419 |
| 2024-06-30 | $385 |
| 2024-03-31 | $353 |
| 2023-12-31 | $430 |
| 2023-09-30 | $383 |
| 2023-06-30 | $341 |
| 2023-03-31 | $360 |
| 2022-12-31 | $366 |
| 2022-09-30 | $335 |
| 2022-06-30 | $298 |
| 2022-03-31 | $306 |
| 2021-12-31 | $342 |
| 2021-09-30 | $309 |
| 2021-06-30 | $281 |
| 2021-03-31 | $279 |
| 2020-12-31 | $313 |
| 2020-09-30 | $248 |
| 2020-06-30 | $186 |
| 2020-03-31 | $192 |
| 2019-12-31 | $296 |
| 2019-09-30 | $254 |
| 2019-06-30 | $230 |
| 2019-03-31 | $215 |
| 2018-12-31 | $273 |
| 2018-09-30 | $223 |
| 2018-06-30 | $205 |
| 2018-03-31 | $199 |
| 2017-12-31 | $256 |
| 2017-09-30 | $199 |
| 2017-06-30 | $185 |
| 2017-03-31 | $176 |
| 2016-12-31 | $223 |
| 2016-09-30 | $185 |
| 2016-06-30 | $170 |
| 2016-03-31 | $167 |
| 2015-12-31 | $212 |
| 2015-09-30 | $168 |
| 2015-06-30 | $169 |
| 2015-03-31 | $160 |
| 2014-12-31 | $216 |
| 2014-09-30 | $167 |
| 2014-06-30 | $201 |
| 2014-03-31 | $180 |
| 2013-12-31 | $236 |
| 2013-09-30 | $193 |
| 2013-06-30 | $202 |
| 2013-03-31 | $175 |
| 2012-12-31 | $241 |
| 2012-09-30 | $210 |
| 2012-06-30 | $188 |
| 2012-03-31 | $190 |
| 2011-12-31 | $218 |
| 2011-09-30 | $189 |
| 2011-06-30 | $184 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |